A US federal court has dismissed all claims in a patent infringement lawsuit filed by Natsoft Corporation and its affiliate Updraft, LLC against hexaware technologies and its subsidiary. The United States District Court for the Northern District of Illinois ruled on June 9, 2026, that the asserted patents claimed broad, abstract ideas rather than specific inventions, rendering them ineligible for patent protection under US law. This decision resulted in the dismissal of nine patents across two patent families and related state-law claims. The initial claim in the litigation was USD 500 million.

Case Background and Ruling

The lawsuit alleged infringement of nine patents spanning two patent families. The Court's decision centered on the deficiency in Natsoft's patents, finding them too abstract to qualify as patentable inventions. Consequently, the Court declined to retain jurisdiction over related state-law claims. While the Court has granted plaintiffs time to file an amended complaint adding a new federal claim, Hexaware maintains that its platforms—Amaze®, Tensai®, and RapidX®—are the result of original engineering and substantial investment, holding its own US patents for methods embodied in these platforms.

Business and Financial Impact

Hexaware Technologies has confirmed that the litigation has caused no material change to its operations, ability to serve customer commitments, partner programs, or financial position. The company anticipates no such changes in the future. The resolution follows a motion to dismiss filed by the company in December 2025.

Hexaware Technologies has entered a strategic collaboration with HBSUK to enhance clinician onboarding efficiency through a digital solution. Announced on June 3, 2026, the partnership aims to address the pressure on healthcare providers, specifically within the NHS where around 7.22 million people are currently awaiting treatment. By digitising recruitment and onboarding, the organisations intend to mobilise clinician capacity quickly while maintaining strict regulatory checks and governance standards.

Solution Overview

The collaboration implements a workforce management system on Journey36’s cloud-based App36 platform. This secure portal allows clinicians to submit credentials, identity documentation, and Right-to-Work evidence. While the platform introduces digital efficiency, HBSUK’s dedicated compliance team continues to oversee verification to ensure accuracy and regulatory adherence. The system orchestrates multiple large language models to accelerate development and is supported by AI governance capabilities through Axonyx.ai.

Operational Benefits

A key highlight of the engagement is the speed of development, allowing feedback to move into production significantly faster than traditional cycles. This agility enables the system to evolve alongside business needs. Further features planned for release in June include rota management, payment reconciliation, and enhancements for HBSUK’s Contact Centre operations.

Executive Commentary

Keith Misson, CEO of HBSUK, highlighted the speed of response to business needs as a key outcome, positioning the firm to better support healthcare providers across the UK. R. Srikrishna, CEO and Executive Director of Hexaware Technologies, noted that the collaborative engineering approach helps streamline complex workflows. Shantanu Baruah, President & Global Head, Healthcare, Life Sciences & Insurance of Hexaware Technologies, added that consolidating fragmented manual steps onto a single AI-enabled platform provides a scalable way to manage clinician workforce operations.